Ignite Creation Date:
2024-05-06 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03058601
Status:
COMPLETED
Last Update Posted:
2019-05-21
First Post:
2017-02-09
Brief Title:
Outcomes in UK ACS Patients Prescribed Ticagrelor
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Health Outcomes of Patients With Acute Coronary Syndromes Prescribed Ticagrelor in UK Primary Care a Retrospective Cohort Study
Status:
COMPLETED
Status Verified Date:
2019-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cohort study using data from Clinical Practice Research Datalink CPRD The study cohort includes all patients who received at least one prescription for ticagrelor for the first time between December 2010 and March 2015 following ACS Patient baseline characteristics will be described Age Gender Body Mass Index Smoking status Sociodemographic status type of ACS and interventions CV history and comorbidities bleeding and respiratory history
The following outcomes will be examined Incidence of vascular events composite MI Stroke vascular death specific vascular event and all cause death incidence of bleeding and incidence of dysponea Time to event for vascular events bleeding and dyspnoea
The following outcomes will be examined Incidence of vascular events composite MI Stroke vascular death specific vascular event and all cause death incidence of bleeding and incidence of dysponea Time to event for vascular events bleeding and dyspnoea
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EUPAS17107 | REGISTRY | ENCePP | None |